Impact of Climate Change Anxiety on Sinusitis Symptoms and Quality of Life Among Adults With Chronic Rhinosinusitis: A Cross-Sectional Study

NCT ID: NCT07119879

Last Updated: 2025-08-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

134 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-01

Study Completion Date

2025-07-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This cross-sectional observational study investigates the relationship between climate change anxiety and chronic rhinosinusitis (CRS) symptom severity and quality of life (QoL) in adults. As climate change continues to influence public health, individuals with chronic respiratory diseases may experience worsened symptoms due to heightened psychological stress and perceived environmental instability. The study utilizes standardized instruments including the SNOT-22 (Sino-Nasal Outcome Test), a QoL scale, and a climate change anxiety questionnaire to evaluate associations among these variables.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Climate change has emerged as a major global health concern, with growing recognition of its psychological impacts, including anxiety, distress, and perceived environmental instability. These psychosocial effects may exacerbate symptoms in chronic inflammatory conditions such as Chronic Rhinosinusitis (CRS), a disease characterized by persistent nasal congestion, facial pressure, and impaired quality of life.

This study aims to explore the correlation between self-perceived climate change anxiety and CRS symptom severity and QoL in an adult population. A total of 134 participants with CRS, aged ≥18 years, were recruited to complete an online Arabic-language survey. The survey included demographic information, the SNOT-22 scale, a validated quality of life questionnaire, and a climate change stress scale.

The primary objective is to assess the association between climate change stress and symptom severity (SNOT-22 total score). The secondary objective is to determine the relationship between climate change anxiety and QoL. The study uses Pearson's correlation analysis to examine these associations.

This research introduces a novel psychosomatic dimension to CRS management by highlighting how environmental and psychological stressors may influence disease burden. Results may inform multidisciplinary approaches for patient care, incorporating environmental awareness and mental health support.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Rhinosinusitis (CRS) Climate Change Anxiety Quality of Life Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adults with Chronic Rhinosinusitis

This cross sectional includes adult participants (≥18 years) with self-reported or physician-diagnosed chronic rhinosinusitis who completed an online questionnaire assessing climate change anxiety, SNOT-22 scores, and quality of life.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Participants must meet all of the following:

Exclusion Criteria

Participants will be excluded if they meet any of the following:

Diagnosis of severe psychiatric or psychological disorders (e.g., schizophrenia, bipolar disorder) History of major chronic illnesses that may confound outcomes (e.g., cardiovascular disease, cancer, chronic neurological disease) Recent nasal or sinus surgery within the past 3 months Incomplete survey responses that prevent data analysis Participants under 18 years of age
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sinai University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amany Gomaa Atiaa

lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sinai university

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB00014233-17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Early-onset Dupilumab Effects in CRSwNP
NCT06188871 WITHDRAWN PHASE4